Bernardo Wealth Planning LLC Sells 91 Shares of UnitedHealth Group Inc (NYSE:UNH)

Bernardo Wealth Planning LLC lowered its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.7% in the third quarter, HoldingsChannel reports. The firm owned 3,238 shares of the healthcare conglomerate’s stock after selling 91 shares during the period. Bernardo Wealth Planning LLC’s holdings in UnitedHealth Group were worth $1,009,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of the stock. JJJ Advisors Inc. boosted its holdings in shares of UnitedHealth Group by 1,820.0% during the third quarter. JJJ Advisors Inc. now owns 96 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 91 shares during the period. Exchange Traded Concepts LLC boosted its holdings in shares of UnitedHealth Group by 140.0% during the second quarter. Exchange Traded Concepts LLC now owns 132 shares of the healthcare conglomerate’s stock worth $39,000 after acquiring an additional 77 shares during the period. Old North State Trust LLC bought a new stake in shares of UnitedHealth Group during the third quarter worth approximately $39,000. Your Advocates Ltd. LLP boosted its holdings in shares of UnitedHealth Group by 33.3% during the second quarter. Your Advocates Ltd. LLP now owns 400 shares of the healthcare conglomerate’s stock worth $44,000 after acquiring an additional 100 shares during the period. Finally, Clean Yield Group boosted its holdings in shares of UnitedHealth Group by 38.5% during the third quarter. Clean Yield Group now owns 144 shares of the healthcare conglomerate’s stock worth $45,000 after acquiring an additional 40 shares during the period. Institutional investors and hedge funds own 86.39% of the company’s stock.

Several brokerages recently issued reports on UNH. Bank of America boosted their price target on UnitedHealth Group from $351.00 to $365.00 and gave the company a “buy” rating in a research note on Friday, August 28th. Oppenheimer boosted their price target on UnitedHealth Group from $353.00 to $375.00 and gave the company an “outperform” rating in a research note on Thursday, October 15th. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $293.00 to $312.00 and gave the company a “buy” rating in a research note on Thursday, July 16th. Citigroup boosted their price target on UnitedHealth Group from $339.00 to $357.00 and gave the company a “buy” rating in a research note on Thursday, July 16th. Finally, SVB Leerink boosted their price target on UnitedHealth Group from $370.00 to $373.00 and gave the company an “outperform” rating in a research note on Thursday, October 15th. Five equities research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $346.68.

In other news, EVP Marianne D. Short sold 10,336 shares of the company’s stock in a transaction on Friday, August 28th. The shares were sold at an average price of $312.34, for a total transaction of $3,228,346.24. Also, EVP Marianne D. Short sold 12,000 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $321.34, for a total transaction of $3,856,080.00. Following the transaction, the executive vice president now owns 140,885 shares of the company’s stock, valued at $45,271,985.90. The disclosure for this sale can be found here. Insiders have sold 37,336 shares of company stock valued at $11,893,276 over the last quarter. Company insiders own 0.80% of the company’s stock.

Shares of NYSE:UNH opened at $327.11 on Monday. The company has a fifty day moving average of $313.06 and a 200-day moving average of $300.72. The company has a market capitalization of $314.18 billion, a PE ratio of 18.99, a price-to-earnings-growth ratio of 1.53 and a beta of 0.68. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.84 and a current ratio of 0.82. UnitedHealth Group Inc has a 52-week low of $187.72 and a 52-week high of $335.65.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.98 by $0.53. The company had revenue of $65.12 billion during the quarter, compared to the consensus estimate of $63.97 billion. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business earned $3.88 earnings per share. On average, equities analysts forecast that UnitedHealth Group Inc will post 16.78 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What are popular green investing opportunities?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.